News Conference News TCT 2025 LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI L.A. McKeown October 27, 2025
News Conference News TCT 2024 SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD L.A. McKeown October 29, 2024
News Conference News TCT 2023 LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI L.A. McKeown October 25, 2023
News Conference News TCT 2020 Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study Caitlin E. Cox October 18, 2020
News Conference News TCT 2020 IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs L.A. McKeown October 18, 2020
Presentation TCT 2020 IN.PACT BTK: A Randomzied Trial of Drug-Coated Balloon Angioplasty in the Infrapopliteal Arteries Presenter: Antonio Micari October 18, 2020
Presentation TCT 2014 DCB in BTK Intervention: Ongoing Trials and Future Perspectives Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Lawrence A. Garcia September 15, 2014
Presentation TCT 2014 CON: There Is No Proof of Efficacy: IN.PACT DEEP Trumps All! Presenter: Dierk Scheinert September 15, 2014
Presentation TCT 2013 Long-term Patency Is Essential Following BTK Intervention for Limb Salvage! Presenter: Thomas Zeller October 28, 2013
Presentation TCT 2013 No Approved BTK Devices in the United States: What Does a Pivotal Device Trial with a Half-chance for Success Look Like? Presenter: Krishna Rocha-Singh October 28, 2013
Presentation TCT 2013 Drug eluting balloon for below the knee angioplasty- one year results from a single center DEB-BTK Registry. Presenter: Grigore Popusoi, Angelo Cioppa, Eugenio Stabile, Luigi Salemme, Vittorio Ambrosini, Tullio Tesorio, Giovanni Sorropago, Linda Cota, Armando Pucciarelli, Giancarlo Biamino, Paolo Rubino January 31, 2013